AMYVID: payments to doctors
Payments that named AMYVID as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $571K
- Providers
- 7,189
- Transactions
- 29,643
- Average per transaction
- $19
The per-transaction average — $19 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,189 providers the average total is $79, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lilly USA, LLC | $570,663 | 99.9% |
| Eli Lilly | $334 | 0.1% |
| Siemens Medical Solutions USA, Inc. | $85 | 0.0% |